The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for L Zeng


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors.EBI
Chinese Academy of Sciences
Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase.EBI
Chinese Academy of Sciences
Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.EBI
Icahn School Of Medicine At Mount Sinai
Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization.EBI
First Affiliated Hospital of Guangzhou Medical University
Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization.EBI
Chinese Academy of Sciences
Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer.EBI
Hangzhou City University
Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment.EBI
Zhejiang University
Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.EBI
Southern Medical University
Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an EBI
Chinese Academy of Sciences
Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-associated factor.EBI
TBA
The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy.EBI
International Institute For Translational Chinese Medicine
Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives.EBI
Chinese Academy of Sciences
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.EBI
St. John'S University
Discovery of a low-systemic-exposure DGAT-1 inhibitor with a picolinoylpyrrolidine-2-carboxylic acid moiety.EBI
Xinxiang Medical University
Pyridinamine-pyridone and pyrimidinamine-pyridone compoundsBDB
Sprint Bioscience
Inhibitors of IRAK4 activityBDB
Merck Sharp & Dohme
Bifunctional compounds and use for reducing uric acid levelsBDB
Acquist
ORA1, a zebrafish olfactory receptor ancestral to all mammalian V1R genes, recognizes 4-hydroxyphenylacetic acid, a putative reproductive pheromone.BDB
German Institute of Human Nutrition Potsdam-Rehbruecke
Chromane compoundsBDB
Comentis